Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-12

Clinical Trial Update: Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination [NA]

View source ↗

Summary

A completed clinical trial evaluating PARAD+ Rhythm Discrimination for reducing inappropriate shocks in tachycardia conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PARAD+ Rhythm Discrimination

Snippet

Sponsor: MicroPort CRM | Conditions: Tachycardia | NA | Status: COMPLETED | Results posted: 2018-02-12